News
Chart Industries' long lead times and multiyear projects shield it from short-term political disruptions. Read why GTLS stock ...
Q4 2024 Earnings Call Transcript May 29, 2025 Roivant Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.22 ...
Opus 4 is Anthropic’s new crown jewel, hailed by the company as its most powerful effort yet and the “world’s best coding ...
A flow chart for patient management in the control arm is provided ... The trial details documented here are consistent with the TAPPS Trial protocol V.6 (date: 06/10/2014). A summary of the trial ...
Enterprise Products Partners offers tax-efficient income, consistent growth, and a strong asset moat. Learn why EPD stock is ...
SAN DIEGO--(BUSINESS WIRE)--Scientist.com, the leading R&D procurement platform for the life sciences, today integrated Trial Insights™—its real‑time clinical‑trial analytics tool—into ...
It’s been a month since testimony began in Karen Read’s second trial for the murder of John O’Keefe, and the new trial has brought a notable change in presentation. “I mean, I didn’t ...
Nearly half of sequencing data labeled as endometriosis lacks true disease representation, highlighting the urgent need for more diverse and accurate tissue sampling to advance research in this ...
Long-simmering tension between Silicon Valley and the press that covers it is surfacing during the Federal Trade Commission’s antitrust trial against Meta. The exchange resurfaced years-old ...
That is the central question posed to a federal jury Monday on the first day of testimony in Sean “Diddy” Combs’ racketeering and sex trafficking trial in New York City. The criminal trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results